Cargando…

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?

Detalles Bibliográficos
Autores principales:	Crocombe, Dominic, O’Brien, Alastair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476838/ https://www.ncbi.nlm.nih.gov/pubmed/37655979 http://dx.doi.org/10.1097/HC9.0000000000000228

Ejemplares similares

Reply: Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?
por: O'Brien, Alastair, et al.
Publicado: (2023)

Glucocorticoids and prostate cancer treatment: friend or foe?
por: Montgomery, Bruce, et al.
Publicado: (2014)

Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011)

Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
por: Protopapas, Adonis A., et al.
Publicado: (2023)

Bacterial toxins: friends or foes?
por: Schmitt, C K, et al.
Publicado: (1999)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
por: Rastrelli, Giulia, et al.
Publicado: (2019)

Intraoperative graft patency validation: Friend or foe?
por: Akhrass, Rami, et al.
Publicado: (2021)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Friend or Foe? Spontaneous Portosystemic Shunts in Cirrhosis—Current Understanding and Future Prospects
por: Rajesh, Sasidharan, et al.
Publicado: (2021)

Functional roles of protein phosphatase 4 in multiple aspects of cellular physiology: a friend and a foe
por: Park, Jaehong, et al.
Publicado: (2020)

PB.02: Magnetic resonance imaging axilla: friend or foe?
por: Hathaway, CF, et al.
Publicado: (2013)

Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022)

Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated Cirrhosis
por: Oyelade, Tope, et al.
Publicado: (2023)

Oxygen for the Newborn: Friend or Foe?
por: Perrone, Serafina, et al.
Publicado: (2023)

Inflammation and Nutrition: Friend or Foe?
por: Stumpf, Franziska, et al.
Publicado: (2023)

Friend and Foe
Publicado: (1890)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

Noradrenaline and the kidney: friends or foes?
por: Bellomo, Rinaldo, et al.
Publicado: (2001)

Candida glabrata, Friend and Foe
por: Tam, Phyllix, et al.
Publicado: (2015)

Oxygen: viral friend or foe?
por: Gan, Esther Shuyi, et al.
Publicado: (2020)

Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019)

Zinc in the Brain: Friend or Foe?
por: Choi, Seunghyuk, et al.
Publicado: (2020)

Iron in Porphyrias: Friend or Foe?
por: Buzzetti, Elena, et al.
Publicado: (2022)

Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021)

Obesity: Friend or foe for osteoporosis
por: Sharma, Sudhaa, et al.
Publicado: (2014)

Alcohol: Its Friends and Foes
Publicado: (1874)

Lithium in Cancer Therapy: Friend or Foe?
por: Yang, Chunhao, et al.
Publicado: (2023)

Microbiota of the gastrointestinal tract: Friend or foe?
por: Senchukova, Marina A
Publicado: (2023)

Extracellular Vesicles of Pseudomonas: Friends and Foes
por: Henriquez, Tania, et al.
Publicado: (2023)

Statins and Cardiomyocyte Metabolism, Friend or Foe?
por: Somers, Tim, et al.
Publicado: (2023)

Extracellular vesicles and COPD: foe or friend?
por: Wu, Jiankang, et al.
Publicado: (2023)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

Type I interferon: friend or foe?
por: Trinchieri, Giorgio
Publicado: (2010)

STAT3 in Cancer—Friend or Foe?
por: Zhang, Hai-Feng, et al.
Publicado: (2014)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

NFKB1 and Cancer: Friend or Foe?
por: Concetti, Julia, et al.
Publicado: (2018)

MDR1 in immunity: friend or foe?
por: Bossennec, Marion, et al.
Publicado: (2018)

EGFR Signaling: Friend or Foe for Cartilage?
por: Qin, Ling, et al.
Publicado: (2019)

Neuroinflammation: friend and foe for ischemic stroke
por: Jayaraj, Richard L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uspfcrh265sse3j6e4p4tf9ovq